Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

48 results about "Arterial canal" patented technology

Radiofrequency ablation controlled electrode catheter for renal artery

The invention relates to a medical apparatus of interventional therapy, and particularly relates to a radiofrequency ablation electrode catheter used for curing refractoriness hypertension through per cutem and blood vessel to enter into renal artery. According to the invention, the technical problem to be solved is that a sympathetic nerve on the arterial canal of the renal artery can be effectively removed, so that damages to the inner wall of the vessel can be reduced. According to the invention, the radiofrequency ablation controlled electrode catheter for renal artery is provided with a catheter body, wherein an electrode is connected with a far-end of the catheter body; a control handle is connected with a near-end of the catheter body; an ablation electrode and a monitoring electrode are arranged at the far-end of the catheter body along the axis of the catheter body; and an interval is arranged between the ablation electrode and the monitoring electrode. Compared with prior art, the invention is in characterized in that no fill orifice is arranged on the ablation electrode; the monitoring electrode adjoins the ablation electrode through the interval; the temperature of the sympathetic nerve which is ablated is monitored during the ablation process, so as to judge a clinical treatment required value is reached; also, the conduction of sympathetic nerve signal acquired through monitoring the electrodes, and the comparison of conduction waveforms of the sympathetic nerve before and after ablation, can provide supplementary means for judging if a surgical operation end is finished or not.
Owner:APT MEDICAL INC

Fixing device for catheter used in hemodialysis of child

The invention relates to the technical field of hemodialysis catheters, in particular to a fixing device for a catheter used in hemodialysis of a child. The invention aims to solve the problems that the fixing position of fixing equipment of a hemodialysis catheter is limited, a hemodialysis catheter is prone to deformation after being fixed, dialysate transmission is affected, and discomfort is easily caused due to the fact that the covering area of a connecting belt is large in the prior art. The fixing device for the catheter used in hemodialysis of the child comprises a dialysis tube bifurcation block and static artery tubes, wherein the static artery tubes are connected to the two sides of the front surface of the dialysis tube bifurcation block, and a connecting mechanism is arranged on one side of the outer side wall of the dialysis tube bifurcation block. According to the fixing device, after being tightened, a rubber band belt is driven by a supporting frame to be tightened again to fix a position, so the hemodialysis catheter can be fixed to a certain position without being limited by the hemodialysis catheter fixing device; length adjustment is conducted through a telescopic sleeve under ventilation control to protect the hemodialysis catheter, so the hemodialysis catheter is prevented from being damaged; and heat dissipation of a area covered by the rubber band is not affected by air generated after an air bag on the rubber band expands.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV

Control method and system of dual plasma molecular adsorption system and storage medium

The invention discloses a control method and system of a dual plasma molecule adsorption system and a storage medium, and the method comprises the steps: obtaining the blood flow in an artery pipeline according to the rotating speed of a blood pump when the dual plasma molecule adsorption system carries out blood purification; determining the plasma flow of the plasma branch according to the plasma separation ratio of the plasma separator and the blood flow in the artery pipeline; according to the plasma flow and the blood purification time of the plasma branch, the first plasma cumulative adsorption quantity of the hemoperfusion device and the second plasma cumulative adsorption quantity of the bilirubin adsorption column are determined; when the first plasma cumulative adsorption quantity is larger than or equal to the first plasma target adsorption quantity of the hemoperfusion device, and/or the second plasma cumulative adsorption quantity is larger than or equal to the second plasma target adsorption quantity of the bilirubin adsorption column, a fault alarm signal is sent out; the blood perfusion device and/or the bilirubin adsorption column in the dual plasma molecule adsorption system are/is prompted to be replaced. In this way, the efficiency of DPMAS treatment can be improved.
Owner:JAFRON BIOMEDICAL

ECMO simulation practical training human body model convenient to exhaust

The invention discloses an ECMO simulation training human body model convenient to exhaust, which comprises a model main body and a simulated heart container arranged on the model main body, the simulated heart container is provided with a main vein tube and an aortic tube, the main vein tube is connected with a vein branch tube, the vein branch tube is detachably connected with a vein needle insertion tube, the aortic tube is connected with a carotid artery tube, and the carotid artery tube is detachably connected with a vein needle insertion tube. The upper end of the carotid artery tube is detachably connected with a first artery needle inserting tube, the upper end of the first artery needle inserting tube is connected with an exhaust funnel communicated with the first artery needle inserting tube, an exhaust hole is formed in the upper end of the exhaust funnel, a floating block capable of floating on the water surface is arranged in the exhaust funnel, and an air inlet communicated with the first artery needle inserting tube is formed in the lower end of the exhaust funnel. And a sealing structure capable of sealing the exhaust hole when the floating block is in a floating state is arranged between the floating block and the exhaust funnel. The human body model can be applied to ECMO simulation practical training, and air in the liquid channel can be conveniently exhausted in the simulation practical training.
Owner:ZHONG SHAN PEOPLES HOSPITAL

Preparation method and application of protein oligopeptide rich in desmosine and isodesmosine

The invention relates to the technical field of polypeptide extraction, in particular to a preparation method and application of protein oligopeptide rich in desmosine and isodesmosine. The inventionprovides the preparation method of the protein oligopeptide. The method comprises the following steps of sequentially carrying out alkali liquor soaking and acid liquor soaking on to-be-extracted tissue, performing grinding until the granularity is 100-200 meshes, carrying out enzymolysis by using alkaline protease and pancreatin, carrying out enzyme deactivation and centrifugation to obtain supernatant, and carrying out fine filtration and nanofiltration to obtain a solution containing the protein oligopeptide, wherein the to-be-extracted tissue is the arterial canal, the ligament, the lung,the fascia, the cartilage or the eggshell membrane. The extracted protein oligopeptide is rich in desmosine and isodesmosine, and the polypeptide with the molecular weight less than 1,000 Da accountsfor 50%-85% of the total polypeptide mass. According to the method, alkali liquor and acid liquor are used for degreasing and impure protein removing, so that residues and pollution of an organic solvent are avoided, operation is easy, and the extraction efficiency is high.
Owner:安徽盛美诺生物技术有限公司

Hemostatic stent for heart great vessel surgery

The invention relates to the technical field of medical apparatus and instruments, in particular to a hemostatic stent for heart great vessel surgery, which is characterized in that a first shell and a second shell can be relatively closed and opened by using a connecting assembly, so that when aorta is clamped and sealed, the first shell and the second shell can be relatively closed and opened; the first shell and the second shell which are oppositely opened are smoothly arranged at any position of an arterial canal in a sleeving mode through the opened opening, installation of the clamping and sealing assemblies on the aorta is conveniently completed, in addition, the two clamping and sealing assemblies are arranged on the first shell and the second shell at the same time, alternate clamping can be conveniently achieved during aorta clamping and sealing hemostasis, and the clamping and sealing efficiency is improved. The problems that in the long-time operation process, if the clamping and sealing assembly is not loosened frequently, the outer wall of the aorta blood vessel is damaged to a certain degree, once the clamping and sealing assembly is loosened, the aorta sprays a large amount of blood, the blood loss amount in the operation is increased, the operation view is affected, and meanwhile the operation risk is increased are effectively avoided.
Owner:王建林

Device for the continuous monitoring of blood characteristic quantities in an external cardiovascular supporting circuit

A device (1) for the continuous monitoring of blood characteristic quantities in an external cardiovascular supporting circuit (2), said circuit (2) comprising a venous line (3), an oxygenator (4), apump (5), and an arterial line (6), comprising: a sensor (7) suitable for the measurement of the venous saturation (SAT V) and a sensor (8) suitable for the measurement of the arterial saturation (SATA) of oxygen; a sensor (11) suitable for the measurement of the flow of blood (Qb) sent by the pump (5) to the oxygenator (4); a sensor (12) suitable for the measurement of the hemoglobin (Hb); dataentering means by the operator; an electronic control unit (14) provided with a microprocessor (15) and operationally connected to a display (16), and further comprising a sensor (19) suitable for themeasurement of the flow of work gas (Gf) and a capnometer (20) adapted to measure the concentration of carbon dioxide in the blood; wherein said microprocessor (15) is provided with means adapted tocalculate the quantity relating to the amount of carbon dioxide removed by the oxygenator (V'CO2ML) and the quantity relating to the amount of oxygen transferred by the oxygenator (V'CO2ML), the microprocessor (15) being programmed to display in numerical form on the display (16) the values of all the quantities measured and calculated and in graphic form at least some of said values, being further provided means for acquiring the quantity relating to the amount of carbon dioxide removed from the patient's lung (V'CO2NL) and the microprocessor being provided with means adapted to calculate thequantity relating to the amount of total removed carbon dioxide (V'CO2total).
Owner:欧赛特有限公司

Blood purifying ultrafiltration device

The invention relates to the technical field of blood purifying medical apparatuses and particularly relates to a blood purifying ultrafiltration device. The blood purifying ultrafiltration device comprises an ultrafilter. The ultrafilter comprises an ultrafilter body and an artery connector and a vein connector arranged on the ultrafilter body; the blood purifying ultrafiltration device further comprises an arterial canal connected to the artery connector and the arterial canal comprises an artery connecting end, an artery switch, a pump pipe, an artery kettle and an artery connector end which are successively arranged, wherein the artery connector end is connected to the artery connector, and a vein pipe is connected to a vein connector; the vein pipe comprises a vein connecting end, a vein switch, a vein kettle and a vein connector end which are successively arranged, wherein the vein connector end is connected to the vein connector. The device has the advantages that 1, the project treatment can be conducted by common blood purifying equipment, so that the cost is relatively low, and the device is conveniently operated by medical care staff and used by patients; 2, the quantity of extracorporeal blood is small, and the treatment risk of patients with cardiac failure is reduced; and 3, the treatment cost of extracorporeal circulation is reduced compared with that of a high-end continuous blood filtering equipment and consumables, and the medical efficiency is improved.
Owner:盐城仁越生物科技有限公司

Extracorporeal blood treatment apparatus

The invention relates to an extracorporeal blood treatment apparatus witha control device (50) for controlling the opening and closing of an arterial line (2) with simultaneous closing and opening of a venous line (3) in a single-lumen-arrangement (10), with which untreated blood is removed through the single-lumen-arrangement (10) and the arterial line (2), led through a blood treatment device (5) and treated blood is fed back through the venous line (3) and the single-lumen-arrangement (10),an arterial line container (20) which is arranged in the arterial line (2) in front of the blood treatment device (5),a venous line container (30) which is arranged in the venous line (3) following the blood treatment device (5),a sensor device (31) for detecting an amount of treated blood being above a limit value in the venous line container (30),a sensor device (21) for detecting an amount of untreated blood being below a limit value in the arterial line container (20),an arterial line closure device (22) for closing the arterial line (2) with simultaneous opening of the venous line (3) in response to a signal A which is transmitted by the sensor device (31) to the arterial line closure device (22),a venous line closure device (32) for closing the venous line (3) with simultaneous opening of the arterial line (2) in response to a signal B which is transmitted by the sensor device (21) to a venous line closure device (32) andat least one pump (40) and is characterized in that a control device (50) is provided, with which a phase volume Vact is adjustable automatically in dependence on the current pumping rate QBP of the at least one pump (40) during a phase to a predefined value Vnom (FIG. 1).
Owner:B BRAUN AVITUM

Application of bexarotene or/and pharmaceutically acceptable salt thereof in preparation of anti-pulmonary arterial hypertension drugs

The invention relates to an application of bexarotene (4-[1-(5, 6, 7, 8-tetrahydro-3, 5, 5, 8, 8-pentamethyl-2-naphthyl) vinyl] benzoic acid) or/and a pharmaceutically acceptable salt thereof in preparation of anti-pulmonary arterial hypertension drugs. The chemical structural formula of bexarotene is shown as a formula I in the specification. According to the application, rat pulmonary artery smooth muscle cells are adopted for investigating the smooth muscle cell proliferation and migration inhibiting effect of bexarotene, and the result shows that bexarotene can obviously inhibit PASMCs proliferation and migration. The monocrotaline-induced rat pulmonary arterial hypertension model is adopted to investigate the anti-pulmonary arterial hypertension vascular remodeling of the bexarotene,and the result shows that the oral administration of the bexarotene can significantly inhibit the increase of the pulmonary arterial pressure and the right ventricular systolic pressure of rats, significantly reduce the NT-proBNP level in the rat plasma, can obviously inhibit thickening of pulmonary artery intima media and reduce the narrow level of pulmonary arteriole lumens, and a safe, effective and economical solution is provided for prevention and treatment of pulmonary arterial hypertension and pulmonary vascular remodeling.
Owner:上海宛文创业孵化器管理合伙企业(有限合伙)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products